Profile
David D.
House is Chief Financial Officer at Armata Pharmaceuticals, Inc. starting in 2026.
Former roles include Vice President-Accounting & Controller at ZO Skin Health, Inc. from 2018 to 2024, Controller at Avid Bioservices, Inc., and Senior Auditor at Windes, Inc. Education includes an undergraduate degree from California State University-Fullerton.
David House active positions
| Companies | Position | Start |
|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Director of Finance/CFO | 2024-08-15 |
Former positions of David House
| Companies | Position | End |
|---|---|---|
ZO Skin Health, Inc.
ZO Skin Health, Inc. Household/Personal CareConsumer Non-Durables Manufactures and retails skincare products through online | Comptroller/Controller/Auditor | 2024-04-30 |
| AVID BIOSERVICES, INC. | Comptroller/Controller/Auditor | - |
Windes, Inc.
Windes, Inc. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Comptroller/Controller/Auditor | - |
Training of David House
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Avid Bioservices, Inc.
Avid Bioservices, Inc. Pharmaceuticals: MajorHealth Technology Engages in the developing and manufacturing of biologics | Health Technology |
California State University-Fullerton
California State University-Fullerton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Windes, Inc.
Windes, Inc. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
ZO Skin Health, Inc.
ZO Skin Health, Inc. Household/Personal CareConsumer Non-Durables Manufactures and retails skincare products through online | Consumer Non-Durables |
Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
- Stock Market
- Insiders
- David House
















